text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 78755-81-4 | Product Number: F0958

Flumazenil


Purity: >99.0%(GC)
Synonyms:
  • Ro 15-1788
Documents:
25MG
€41.00
1   2  
100MG
€122.00
2   ≥20 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number F0958
Purity / Analysis Method >99.0%(GC)
Molecular Formula / Molecular Weight C__1__5H__1__4FN__3O__3 = 303.29  
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
CAS RN 78755-81-4
Reaxys Registry Number 4763661
PubChem Substance ID 253662580
Merck Index (14) 4135
MDL Number

MFCD00242764

Specifications
Appearance White to Almost white powder to crystal
Purity(GC) min. 99.0 %
Melting point 198.0 to 202.0 °C
Properties (reference)
Melting Point 200 °C
GHS
Related Laws:
RTECS# N12922170
Transport Information:
HS Number 2933998090
Application
Flumazenil: a potent benzodiazepine receptor antagonist

Flumazenil (code name Ro 15-1788) was first developed as an anti-anxiety agent in 1979. In subsequent studies have been demonstrated that flumazenil acts as a potent benzodiazepine receptor antagonist and a partial benzodiazepine receptor agonist. Flumazenil inhibits the central effects of benzodiazepine agonists by competing with these drugs for the benzodiazepine receptor. Then, flumazenil is used for the treatment of benzodiazepine overdoses. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents